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Proinflammatory cytokines and chemokines are often detected in brain tissue of patients with neurological diseases such as multiple sclerosis
(MS), HIV-associated dementia (HAD) and Alzheimer's disease (AD). We have utilized a mouse model of retrovirus-induced neurological disease
to examine how these proinflammatory responses contribute to neuropathogenesis. In previous studies with this model, a correlation was found
between neurovirulence and cytokine and chemokine expression. However, it was unclear whether the induction of these cytokines and
chemokines was in response to specific virus envelope determinants or was regulated by the level of virus infection in the brain. In the current
study, we demonstrated that multiple polytropic retroviruses induced cytokine and chemokine mRNA expression following increased virus levels
in the brain. Increased virus levels of polytropic viruses also correlated with increased neuropathogenesis. In contrast, the ecotropic retrovirus,
FB29, did not induce cytokine or chemokine mRNA expression or neurological disease, despite virus levels either similar to or higher than the
polytropic retroviruses. As polytropic and ecotropic viruses utilize different receptors for entry, these receptors may play a critical role in the
induction of these innate immune responses in the brain.
© 2006 Elsevier Inc. All rights reserved.Keywords: Chemokines; Cytokines; Brain; Neuropathogenesis; Microglia; Retrovirus; MouseIntroduction
Insult or injury to the central nervous system (CNS) is often
associated with the activation of the innate immune response
and the production of proinflammatory cytokines and chemo-
kines (Bajetto et al., 2001; Mennicken et al., 1999). Addition-
ally, increased cytokine/chemokine expression correlates with
pathogenesis in several neurological disorders including multi-
ple sclerosis (MS), Alzheimer's disease (AD), and HIV-
associated dementia (HAD) (Conant et al., 1998; Eikelenboom
et al., 2002; Glass et al., 1993; Gonzalez et al., 2002; Mahad and
Ransohoff, 2003; McManus et al., 1998; Sun et al., 2003;
VanDer et al., 1999; Wesselingh et al., 1993; Xia and Hyman,
1999). Therefore, it is important to determine the factors that⁎ Corresponding author. Fax: +1 225 578 9701.
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doi:10.1016/j.virol.2006.06.016trigger the induction of proinflammatory responses and to
identify which cytokines contribute to the pathogenic process in
the brain.
We have used the mouse model of polytropic retrovirus
infection to examine the contribution of proinflammatory
cytokines in the development of neurological disease. In this
model, intraperitoneal (i.p.) infection of neonatal mice with the
retrovirus, Fr98, results in the development of a neurological
disease with clinical signs of severe ataxia and seizures (Portis
et al., 1995). The main cell types infected by virus are
endothelial cells, microglia and macrophages (Poulsen et al.,
1999; Poulsen et al., 1998; Robertson et al., 1997). The primary
pathology associated with disease development is gliosis with
activated astrocytes and microglia and no detectable increase in
lymphocytic infiltration as measured by immunohistochemistry
or mRNA analysis (Peterson et al., 2001; Portis et al., 1995;
Robertson et al., 1997). Despite the lack of lymphocytic
144 K.E. Peterson et al. / Virology 354 (2006) 143–153infiltration, the development of disease correlates with
increased production of proinflammatory cytokines in the
brain. Increased expression of Tnf(TNFα), Ccl2(MCP-1), Ccl3
(MIP-α), Ccl4(MIP-β), Ccl5(RANTES) and Cxcl10(IP-10)
mRNA was detected 2 to 3 days prior to the onset of Fr98-
induced neurological disease (Peterson et al., 2001). In addition,
IL-1α and Cxcl1(MIP-2) mRNA expression was upregulated at
the time of clinical signs of disease (Peterson et al., 2001).
Knockout mice and antibody blocking experiments have
demonstrated a role for at least two of these cytokines, TNFα
and CCL2(MCP-1), in Fr98-mediated neurological disease
(Peterson et al., 2004a, 2004b).
Intraperitoneal infection of neonatal mice with another
murine polytropic retrovirus, Fr54, does not induce either
neurovirulence or cytokine upregulation despite the presence of
virus in the brain (Portis et al., 1995). Fr54 differs from Fr98
primarily in the envelope protein and lacks both neurovirulent
determinants encoded by the Fr98 envelope gene (Portis et al.,
1995). Additionally, Fr54 infects endothelia and microglia/
macrophages in the brain at a two to three-fold lower level than
Fr98 (Hasenkrug et al., 1996; Robertson et al., 1997). Thus,
either virus-specific envelope sequences or virus-specific
differences in infection of target cells could be determining
factors in the induction of proinflammatory cytokines and
chemokines and neurological disease.
In a previous study, intraventricular inoculation of Fr54-
infected neural stem cells (NSC) resulted in less endothelial cell
infection, but an increase in spread of the virus to resident
microglia/macrophages, resulting in a two to three fold increase
of virus in the CNS, and was associated with a severe clinical
brain disease (Poulsen et al., 1999). However, the neuroin-
flammatory response induced by Fr54-NSC was not examined,
and therefore, it was not clear whether the pathogenesis of this
disease was similar to the disease induced by Fr98. In the
current study, we studied the levels and sources of proin-
flammatory cytokines and chemokines induced in vivo by Fr54-
NSC as well as by NSC infected with other polytropic or
ecotropic murine retroviruses. The results indicated that viral
envelope sequences associated with polytropic envelope
receptor specificity played an important role in induction of
cytokines and chemokines associated with this brain disease.
Cytokine and chemokine mRNA analysis of microglia cells
from Fr54-NSC-inoculated mice demonstrated that these cells
produced Ccl3(MIP-1α) and Ccl4(MIP-1β) mRNA in response
to Fr54 infection, while astrocytes were the source of Ccl2
(MCP-1) mRNA.
Results
Increased infection of microglia by Fr54 results in chemokine
expression
In previous studies, inoculation of Fr54-infected NSC
(Fr54-NSC) directly into the ventricles of neonatal mice
resulted in increased virus spread to microglia/macrophages
and the development of neurological disease (Poulsen et al.,
1999). To determine if Fr54-NSC inoculation also inducedupregulation of proinflammatory cytokines and chemokines
associated with Fr98-induced disease, we analyzed mRNA
expression in Fr54-NSC-inoculated mice. Similar to previous
results (Poulsen et al., 1999), mice inoculated with Fr54-NSC
developed clinical signs of severe ataxia and seizures by 3 to
4 weeks post-inoculation (Fig. 1A). The amount of virus
present in the brain of Fr54-NSC-inoculated mice was three-
fold higher than that observed in Fr54 i.p-infected mice and
slightly higher than the levels observed in Fr98 i.p-infected
mice as measured by virus gag protein (Fig. 1B) or virus gag
mRNA (data not shown). In addition, a high level of
microglial infection was observed in Fr54-NSC-inoculated
mice (Fig. 2A) as reported previously (Poulsen et al., 1999).
To confirm that microglia were actually infected with Fr54,
tissue sections from Fr54-NSC-inoculated mice were dual-
stained for viral RNA by in situ hybridization (Fig. 2B, black
arrows) and for microglia/macrophages using the marker,
Iba1 (Fig. 2B, white arrows). Many of the virus-infected cells
were positive for Iba1 indicating that brain microglia/
macrophages were infected with Fr54. However, some
virus-infected cells were not Iba1-positive, and these were
possibly either the inoculated NSC, infected endothelia or
oligodendrocytes.
Analysis of mRNA levels revealed that Fr54-NSC inocula-
tion induced the same cytokines at similar levels to those
observed in Fr98-infected mice (Fig. 1C). In contrast, mock-
infected NSC (mock-NSC) inoculation did not induce neuro-
logical disease or upregulation of the proinflammatory
cytokines. Thus, increasing the level of microglial infection
by Fr54 correlated with the upregulation of proinflammatory
cytokines in the brain and the development of clinical disease.
NSC inoculation of the ecotropic retrovirus, FB29, does not
induce disease
The ability of Fr54 to induce cytokines and cause
neurological disease suggested that any retrovirus at a high
viral burden in the brain may be able to upregulate cytokine
production. Therefore, NSC were infected with another
avirulent murine retrovirus, FB29. FB29 contains the same
LTR, gag and pol genes as Fr54 and Fr98, but uses a different
receptor to infect its target cells such as microglia and
endothelia (Portis et al., 1995). Interestingly, the amount of
virus gag protein in the brains of mice inoculated with FB29-
infected NSC (FB29-NSC) was 10-fold higher than that
observed in either Fr54-NSC or Fr98 i.p. inoculated mice
(Fig. 1B), with most of the infected cells appearing to be
microglia by immunohistochemistry (data not shown). How-
ever, these mice did not display any signs of neurological
disease (Fig. 1A). Despite the high virus levels in the brain,
mRNA for only one chemokine, Ccl2(MCP-1), was elevated
by FB29-NSC inoculation (Fig. 1C). This level was
significantly lower than that found in Fr54-NSC-inoculated
mice (Fig. 1C) and was not consistently upregulated (Fig.
3D). Thus, a high retrovirus load was not sufficient for the
induction of most proinflammatory cytokines and chemokines
in the brain.
Fig. 1. Induction of neurological disease and cytokine expression following Fr54-NSC inoculation. Neonatal IRW mice were inoculated with 104 FFU of virus or 105
infected-NSC as described in the Materials and methods. (A) Mice were monitored for the development of clinical signs of ataxia and seizures. Data are presented as
the percentage of mice with clinical signs of disease for seven to fifteen mice per group. (B) Amount of virus gag (p30) protein per milligram of brain tissue in mice
infected i.p. with Fr54 or Fr98 or inoculated with Fr54 or FB29-infected NSC. Tissue was removed at 14 to 21 days post-infection at the time of neurological disease in
Fr54-NSC and Fr98-infected mice or at age-matched times for mock-NSC, FB29-NSC and Fr54-infected mice. Virus gag protein levels were determined by ELISA
assay and are presented as ng of p30 per mg of brain tissue homogenate. Data are the mean±standard error of four to eight mice per group. (C) Cytokine mRNA
expression in the brains of mice at 14 to 21 days post-inoculation as detected by RNase Protection Assay. Data are expressed as gene expression relative to the
expression levels in Fr98-infected mice as described in the Materials and methods. A value of 100% indicates mRNA expression at the same level found in Fr98-
infected mice. Data are the mean±standard error for four to eight mice per group. Statistical analysis was performed using a one-way ANOVAwith the Newman–
Keuls post-test. The P value for Fr54-NSC versus all other groups was <0.001 for CCL2, CCL3, CCL4, CCL5 and CXCL10; <0.01 for CXCL1 and IL-1a; and <0.05
for TNα. No significant differences were observed between the mock-NSC, FB29-NSC and Fr54 i.p. groups.
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chemokine expression
The primary difference between Fr54 and FB29 is the
envelope protein with Fr54 encoding a polytropic envelope
and FB29 encoding an ecotropic envelope. To determine if
high virus titers of other polytropic retroviruses induced
clinical disease as well as cytokine and chemokine responses
in the brain, we inoculated mice with NSC infected with
two additional polytropic viruses, EC and MN2PTb, that
normally replicate at low levels in the CNS. EC is a virus
which induces a slow form of neurological disease with
limited induction of cytokines and chemokines (Hasenkrug
et al., 1996; Poulsen et al., 1998). MN2PTb is an avirulent
virus isolated after a Moloney virus infection. MN2PTb
contains a polytropic env similar, but not identical, to Fr54
(data not shown). Fr98-infected NSC were also used as an
additional positive control. High levels of virus gag protein
p30 were found following inoculation of NSC infected by
each of the viruses tested (Fig. 3A). NSC inoculation
increased the pathogenicity of all four polytropic viruses, butnot the ecotropic virus, FB29 (Table 1). In addition,
significant upregulation of cytokine and chemokine mRNA
expression was noted in all of the mice inoculated with
polytropic virus infected NSC (Fr98-NSC, Fr54-NSC, EC-
NSC and MN2PTb-NSC) compared to mock-NSC or FB29-
NSC (Figs. 3B–I). Thus the ability to induce CNS disease
appeared to be common to all polytropic viruses tested so
far, although there remain important virulence differences
among these polytropic viruses.
Coinfection of Fr54 and FMuLV57 also induces CNS disease
with increased cytokine and chemokine expression
Coinfection of polytropic retroviruses and ecotropic retro-
viruses has been reported to enhance the spread of polytropic
retrovirus through pseudotyping of the polytropic genome
(Lavignon and Evans, 1996). We used coinfection of Fr54
with an avirulent ecotropic virus, FMuLV57, as an alternative
method to increase Fr54 infection of microglia cells to rule
out the possibility that the Fr54-NSC were the source of the
increased cytokines and chemokines in the brain. Mice
Fig. 2. (A) Immunohistochemistry staining of a midsagittal brain section of Fr54-NSC-inoculated mouse with goat anti-gp70 (envelope) antibodies. Mag. 200×. (B) In
situ hybridization analysis of virus env RNA expression (red color, black arrows) and Iba1 immunohistochemistry (brown color, white arrows) of same animal
analyzed in panel A. Mag. 1000×. (C, D) Cultured microglia/macrophage cells isolated by percoll gradient, stained for (C) CD11b or (D) virus envelope protein by
immunochemistry as described in the Materials and methods. Positive cells were detected with AEC (red) stain. Mag. 400×. (E–F) In situ hybridization analysis for
Ccl2 mRNA (white arrows) as detected by Fast Red (red stain). Sections subsequently underwent immunohistochemistry analysis for GFAP (black arrows) as detected
by DAB (brown stain). Magnification (A) 200× (B) 1000× (C–F) 400×. All photos were taken on an Olympus microscope with a digital camera using PictureFrame
software (Optronics, Galeta, CA). Cytokine expression was observed between FMuLV57and Fr54 infected mice.
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in the amount of infectious Fr54 virus in the brain compared
to mice infected with Fr54 alone (Fig. 4B), and this
coinfection resulted in the development of neurological
disease similar to that observed with Fr54-NSC inoculation
(Fig. 4A). Coinfection also induced a significant upregulation
of proinflammatory cytokine and chemokine genes compared
to infection with Fr54 or FMuLV57 alone (Fig. 3C). Thus,
infected NSC were not required for cytokine and chemokine
expression induced by Fr54, indicating that these cells were
not the source of the cytokines and chemokines in the CNS.
Production of cytokines and chemokines by microglia and
astrocytes
The influence of increased virus infection of microglia on
Fr54-induced cytokine expression suggests that the infectedmicroglia/macrophages may be the primary cells responsible
for the production of cytokines and chemokines. To test this
possibility, we enriched microglia/macrophages (MG) from
brain tissue of mock-NSC and Fr54-NSC-inoculated mice by
percoll gradient. The resulting cell population was greater
than 90% CD11b-positive cells by immunohistochemical
staining (Fig. 2C) and flow cytometry (data not shown),
contained both infected and uninfected cells (Fig. 2D) and
was highly enriched for the MG gene F4/80 (Fig. 5A).
Surprisingly, the only cytokine or chemokine mRNAs
consistently detected in the MG population from Fr54-
NSC-inoculated mice were Ccl3(MIP-1α) and Ccl4(MIP-1β)
(Fig. 5B, data not shown). There was inconsistent expres-
sion of Ccl5(RANTES) and Tnf(TNFα) (Fig. 5B, data not
shown). The high levels of Ccl3(MIP-1α) and Ccl4(MIP-
1β) mRNA in the microglia/macrophage population sug-
gested that these cells may be the primary source of these
Fig. 3. Virus Gag protein (A) and cytokine/chemokine mRNA (B–I) expression in the brains of mice inoculated with mock, FB29, Fr98, Fr54, EC or
MN2PTb-infected NSC. Mice were removed at the time of clinical disease or at days 18–21 post-infection for mock and FB29-NSC-inoculated mice. Data are
the mean±standard error for four to seven mice per group. Statistical analysis was performed using a one-way ANOVA with the Dunnet's post-test with all
groups compared against the mock-NSC control.
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Ccl2(MCP-1) and Cxcl10(IP-10), found increased in the
whole brain, was not detected in the purified MG population
at all. Similar results were also observed in mice infected
with Fr98 by the i.p. route (Fig. 5C).
In a previous study, astrocytes were found to be the primary
source of Ccl2(MCP-1) mRNA in Fr98-infected mice
(Peterson et al., 2004a, 2004b). Analysis of brain tissue
sections from Fr54-NSC-inoculated mice also demonstrated
Ccl2(MCP-1)-positive astrocytes by in situ hybridization andimmunohistochemical analysis (Figs. 2E, F). These cells were
located in multiple areas including the thalamus, hippocampus,
cortex, cerebellum and brainstem. In contrast, no Ccl2(MCP-
1)-positive cells were detected in the brain of mice infected
with Fr54 using the i.p. route, although a few Ccl2(MCP-1)-
positive cells were present in the brain stem. The production of
Ccl3(MIP-1α) and Ccl4(MIP-1β) mRNA by microglia and
Ccl2(MCP-1) mRNA by astrocytes in both Fr54-NSC and
Fr98-inoculated mice suggested that there was a common
pathway for cytokine and chemokine induction by both
Table 1
Polytropic retrovirus-infected neural stem cells increase severity of neurological
disease
Virus Tropism Route of infection
Intraperitoneal a Intraventricular (NSC) b
Fr54 Polytropic No disease 25 dpi c
Fr98 Polytropic 15 dpi c 12 dpi
EC Polytropic 37 dpi 18 dpi
MN2PTb Polytropic No disease 60 dpi
FB29 Ecotropic No disease No disease
a Cell-free virus was inoculated ip (104 FFU).
b Virus-infected neural stem cells were inoculated into the lateral ventricles of
the brain as previously described (Poulsen et al., 1999).
c Mean day post-infection for onset of neurological disease.
148 K.E. Peterson et al. / Virology 354 (2006) 143–153viruses, which correlated with high levels of MG infection and
clinical CNS disease.
Discussion
In the current study, a high level of infection of microglia by
Fr54 and other polytropic retroviruses, either by coinfection or
by inoculation of infected NSC, resulted in disease associatedFig. 4. Induction of neurological disease and cytokine expression following Fr54 co
FMuLV57 or Fr54 or coinfected with 104 FFU of each virus. (A)Mice were followed f
as the percentage of mice with ataxia for 6 to 12 mice per group. (B) FFU of virus obtai
viruses. Data are presented as the mean±standard error of FFU per 100 μg of brain tiss
significant (p=0.03) difference was observed between the number of polytropic FFU
mRNA expression in the brains of mice at 21 days post-inoculation was analyzed as d
group. Statistical analysis was performed using a one-way ANOVAwith the Newman–
or FMuLV57 infected mice was <0.001 for CCL2, CCL4, CCL5, CXCL10 and IL-1with the upregulation of proinflammatory chemokines and
cytokines. However, microglial infection to similar levels by the
ecotropic murine retrovirus, FB29, did not induce a similar
upregulation of cytokine or chemokine expression (Fig. 1C).
The difference between Fr54 and FB29 in cytokine and
chemokine induction may result from virus stimulation of the
cellular receptor for Fr54, but not the receptor for FB29. FB29,
like other ecotropic retroviruses, uses the Solute Carrier Family
7 (cationic amino acid transporter) member 1 (SLC7a1, also
known as CAT1) to infect cells (Kim et al., 1991; Wang et al.,
1991). In contrast, polytropic viruses such as Fr54 and Fr98
utilize the cellular receptor, xenotropic/polytropic receptor 1
(XPR1, also known as RMC1) (Tailor et al., 1999; Yang et al.,
1999). Although the actual function of XPR1 is unknown, it is
predicted to be involved in G protein signal transduction based
on similarities to the yeast protein, SYG1, and the presence of
an SPX domain (Yang et al., 1999). Possibly, virus envelope
binding of XPR1, but not SLC7a1, induces microglial
activation, initiating a cytokine/chemokine cascade in the
brain. Differences in receptor signaling could also explain the
inability of NSC infected with the amphotropic retrovirus,
4070A, to induced neurological disease, despite high levels of
virus infection (Traister and Lynch, 2002).infection with FMuLV57. Neonatal IRW mice were inoculated with 104 FFU of
or clinical signs of ataxia and seizures as described in Fig. 1A. Data are presented
ned from brain homogenates of mice infected with either Fr54, FMuLV57 or both
ue for four mice per group. Statistics were performed usingMann-Whitney test. A
in FMuLV57/Fr54 infected mice compared to Fr54 infected mice. (C) Cytokine
escribed for Fig. 1C. Data are the mean±standard error of four to eight mice per
Keuls post-test. The P value for FMuLV57/Fr54 infected mice versus either Fr54
a; <0.01 for CCL3 and was not significant (>0.05) for CXCL1 and TNFα.
Fig. 5. (A) Enrichment of microglia/macrophages using a percoll gradient. Brain
tissue was homogenized and separated by a percoll step gradient as described in
the Materials and methods. Prior to layering cells on a percoll gradient, an
aliquot of cells was removed for RNA extraction (whole brain). RNA was
extracted from that fraction as well as the two fractions generated by the percoll
gradient at the 0/35% interface (non-microglia) and the 35/70% interface
(microglia). The total RNAwas then analyzed for Gfap (•) or F4/80 (○) mRNA
expression. RNA analysis of this cell population confirmed the enrichment for
microglial cells with a 500- to 1000-fold increase in the expression of the
microglial marker F4/80 in this population compared to whole brain. mRNA
expression of the astrocyte marker, Gfap, was greatly reduced in the microglia
population. Data are shown as the fold expression of Gfap or F4/80 relative to
GAPDH and represents three separate animals. (B) Cytokine expression by
microglia cells in mock-NSC and Fr54-NSC-inoculated mice. Microglia cells
isolated in the 35/70% interface by percoll gradient were analyzed by RNAse
Protection assay. Due to the low amounts of mRNA obtained from microglia
cells of individual mice, the gel was exposed to a Phosphor-imaging cassette
(Amersham Biosciences, Piscataway, NJ), for 10 days for the detection of
cytokine mRNA. Results of microglia from three individual mice are shown for
each group. (C) Cytokine expression by microglia/macrophage cells from mock,
Fr54 or Fr98 i.p. infected mice at 14 days post-infection. Data were calculated as
described for Fig. 1C.
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chemokine expression may also be due to factors other than
the direct interaction of the envelope with the virus receptors.For example, independent of interactions with the viral
receptors, the envelope may be toxic to certain cell types
including neurons or glia, leading to the release of factors that
stimulate cytokine and chemokine production. In contrast, the
neuropathogenesis of the ecotropic murine retroviruses,
FrCasE and Moloney ts1, has been linked to misfolding of
the envelope protein and the induction of endoplasmic
reticulum stress responses (Dimcheff et al., 2003; Dimcheff
et al., 2004; Kim et al., 2004; Liu et al., 2004). However, so
far we have found no evidence supporting a similar
mechanism of pathogenesis with the polytropic murine
retroviruses (data not shown). It is also possible that
polytropic viruses induce a strong type I interferon response,
as suggested by the production of Cxcl10(IP10) mRNA (Fig.
3I). The production of type I interferons may initiate an anti-
viral response that leads to the subsequent production of other
proinflammatory cytokines and chemokines.
Although infected microglia appear to have a critical role in
cytokine and chemokine induction in the brain, they do not
appear to be the sole or even the primary source. For example,
Ccl2(MCP-1) is produced by astrocytes after Fr54-NSC (Fig.
2D) and Fr98 infection as well as other retrovirus infections and
neurological diseases (Conant et al., 1998; Peterson et al.,
2004a, 2004b; VanDer et al., 1999). In the instance of Fr54-
NSC and Fr98-induced disease, dual staining for Ccl2(MCP-1)
mRNA and virus envelope protein demonstrated that Ccl2
(MCP-1) -producing astrocytes were not infected (data not
shown) (Peterson et al., 2004a, 2004b). Possibly, microglia
activated by retrovirus infection produce soluble factors such as
CCL3(MIP-1α) and CCL4(MIP-1β) that stimulate astrocytes to
produce CCL2(MCP-1). Alternatively, retroviral envelope
proteins may interact with cellular receptors on astrocytes and
stimulate these cells to produce CCL2(MCP-1).
The production of Ccl3(MIP-1α) and Ccl4(MIP-1β) mRNA
by the microglia/macrophage population in the brains of Fr98
and Fr54-NSC-inoculated mice suggest that these chemokines
play an important role in neurovirulence. Additionally,
increased expression of these two chemokines correlated with
neurovirulence induced by Fr98, Fr54-NSC and Fr54/
FMuLV57 inoculation. Both CCL3(MIP-1α) and CCL4(MIP-
1β) bind to the chemokine receptor CCR5 (Boring et al., 1996).
However, mice deficient in CCR5 infected with Fr98 developed
neurological disease with the same severity and kinetics as wild-
type mice (Peterson et al., 2004a, 2004b). Therefore, CCR5 is
not required for this disease. Nevertheless, CCL3(MIP-1α),
which binds to both CCR5 and CCR1, may contribute to
pathogenesis by signaling through the CCR1 receptor (Boring
et al., 1996; Post et al., 1995). In contrast, since CCR5 is the
primary receptor for CCL4(MIP-1β), this chemokine may not
play an essential role in this model.
The present study indicated that the proinflammatory
cytokine/chemokine response to virus infection can be
influenced both by the amount of virus in the brain as well
as the identity of viral envelope proteins. Similarly, the ability
of HIV variants to induce pathogenic cytokine/chemokine
responses in the brain may be dependent upon the level of
HIV infection as well as the ability of HIV envelope to directly
150 K.E. Peterson et al. / Virology 354 (2006) 143–153stimulate its coreceptors, such as CCR5 and CXCR4, on
microglia and macrophages. In vitro studies have demon-
strated that envelope variants of HIV can differ in their ability
to induce CCL3(MIP-1α), CCL4(MIP-1β), CCL5(RANTES)
and TNFα in macrophages (Choe et al., 2001). Thus, the lack
of increased cytokine or chemokine production in some
patients with detectable HIV in the brain may be due to the




Inbred Rocky Mountain White (IRW) mice were bred and
housed at the Rocky Mountain Laboratories animal facility. All
animal experiments were carried out in accordance with the
regulations of the Rocky Mountain Laboratories Animal Care
and Use Committee and the guidelines of the NIH.
Viruses and intraperitoneal (i.p.) infection and antibody
treatment of mice
The construction of virus clones FB29, Fr54, EC and Fr98
has been previously described (Portis et al., 1995). Virus stocks
were prepared from the supernatants of confluently infected
Mus dunni fibroblast cells. Virus titers were determined by
focus forming assays using the envelope-specific monoclonal
antibodies 514 and 720 (Robertson et al., 1991). For
intraperitoneal inoculation, IRW mice were injected with 104
focus forming units (FFU) of virus within 24 h of birth. Mice
were observed daily for clinical signs of CNS disease, which
was characterized by obvious signs of ataxia and/or seizures
(Portis et al., 1995).
Virus inoculation using neural stem cells
The use of the neural stem cell line C17.2 as a vehicle for
delivery of virus to the brain has previously been reported
(Lynch et al., 1999; Poulsen et al., 1999; Traister and Lynch,
2002). C17.2 neural stem cells (NSC) were maintained in
DMEM with 1 mM sodium pyruvate and 10% fetal calf serum
in Primaria tissue culture flasks. NSCs were infected by
culturing 1×105 cells with 4 μg/ml polybrene and 105 FFU of
Fr54 or FB29 for 48 h. Cells were passaged until confluently
infected. Cells were analyzed for virus infection by immuno-
fluorescence using the antibodies 514 or 720 (Robertson et al.,
1991). Prior to inoculation, non-confluent flasks of Fr54, FB29,
or mock-infected NSCs were harvested using 0.25% trypsin in
0.01% EDTA, washed twice in phosphate-buffered saline
(PBS), and resuspended at 7.5×107 cells per ml in PBS with
0.2% trypan blue. Mice, within 24 h of birth, were anesthetized
by hypothermia, and 4 μl of NSC suspension was injected into
each ventricle using a Hamilton syringe with a 30-gauge needle
for a final inoculum of 6×105 NSC per mouse. Correct
inoculation of cells into the ventricles was monitored by
observing trypan blue staining in the ventricles. C17.2 neuralstem cells were previously modified to produce β-gal as a
method of detection (Lynch et al., 1999). Immunohistochem-
istry analysis of β-gal expression from sagittal and coronal
brain tissue sections indicated the presence NSC in multiple
regions of the brain including the olfactory bulbs, cortex,
hippocampus, thalamus, and cerebellum (Poulsen et al., 1999).
Morphological analysis indicated these did not undergo
apoptosis (data not shown). Immunohistochemistry analysis
of virus protein expression was performed to confirm the spread
of virus from NSC to microglia as previously described
(Poulsen et al., 1999). NSC-inoculated mice were followed
for clinical signs for 9 weeks post-inoculation and were
recorded as having disease when signs of severe ataxia and/or
seizures were apparent. Statistical analysis of disease develop-
ment was done using Kaplan-Meir survival curve analysis using
Graph-Pad Prism software.
Enrichment and characterization of microglia/macrophages
Infected mice were exsanguinated by axillary incision under
deep isoflurane anaesthesia. Brain tissue was immediately
removed from mice and placed in individual wells of a 6-well
plate containing 6 ml of 2% FBS diluted in phosphate-buffered
saline (PBS) on ice. Each brain was minced with scissors and
transferred to an ice-cold Dounce homogenizer. Brain tissue
was disrupted with a loose fitting pestle using 5 to 10 strokes per
sample. The homogenate was then passed through a 100-μm
nylon cell strainer (BD Biosciences, San Jose, CA) and
resuspended in 4 ml of 70% percoll/PBS. The cell suspension
was then layered underneath a 0 to 35% step percoll gradient
using two 15-ml tube gradients for each brain sample. The
gradients were then centrifuged at 2300 RPM for 45 min at
room temperature. Following centrifugation, the layer of cells at
the 0–35% interface and 35–70% interface were separately
collected, rinsed in PBS and either seeded on BD Falcon 8-
chamber slides (BD Biosciences), analyzed by flow cytometery,
or processed for RNA. RNAwas extracted using the Statagene
(La Jolla, CA) miniprep RNA isolation kit following manu-
factures recommended protocol. For flow cytometeric analysis,
cells were labeled using anti-F4/80 monoclonal antibodies
generated from the hybridoma HB-198(ATCC) with a FITC-
labeled anti-rat secondary antibody and analyzed on a BD
FACScan (BD Biosciences). Cells were greater than 90%
positive for F4/80 by flow cytometeric analysis. Cells added to
8-chamber slides were incubated in macrophage serum-free
media (Invitrogen) for three to five days, fixed with 95%
ethanol and stained using rat anti-mouse CD11b or goat anti-
gp70 antibodies. Positive cells were detected using horse radish
peroxidase (HRP)-conjugated anti-rat or anti-goat antibodies
(Zymed Laboratories) and developed using the substrate, 3-
amino-9-ethylcarbazole (AEC) (Sigma).
ELISA Assay for virus gag protein
Infected mice were exsanguinated by axillary incision under
deep isoflurane anesthesia. Brains were removed from infected
mice at the time of neurological disease or as indicated and
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sections were immediately frozen in liquid nitrogen and stored
at −80 °C. For analysis of virus gag protein levels, brain tissue
was homogenized in 0.5% NP-40 containing 0.01 M Tris base,
0.15 M NaCl, 0.001 M EDTA (pH 7.4) using Kontes
Disposable Pellet Pestles (Fisher Scientific) and cordless
motor to a final concentration of 10% weight/volume. The
homogenates were spun for 1 min at 14,000 RPM to remove
debris and stored at −20 °C until use. Brain homogenates were
analyzed for virus gag levels using the p30 virus gag ELISA
assay previously described (Poulsen et al., 1999; Wehrly and
Chesebro, 1997). In short, 96-well Immulon II plates were
coated with 100 μl/well of the rat monoclonal antibody 18-7,
blocked with 5% fetal bovine serum/PBS. Samples were serial
diluted from the original 10% homogenate with six dilutions
analyzed for each sample. A standard curve generated from a
known concentration of a gradient-purified virus was used for
each ELISA plate. Plates were developed using a rabbit anti-p30
polyclonal antibody, a donkey anti-rabbit HRP-labeled second-
ary antibody and tetramethylbenzidine (TMB) substrate. Plates
were read using a wavelength of 450 nm.
Focal immunoassay for ecotropic and polytropic retroviruses
Focal immunoassays for the detection and differentiation of
polytropic and ecotropic retroviruses were performed as
previously described (Evans and Morrey, 1987; Sitbon et al.,
1985). In short, brain tissue was removed from infected mice,
homogenized and overlaid onto NIH 3T3 cells. FMuLV57 foci
were detected using the monoclonal antibody 48 and Fr54 foci
were detected using the monoclonal antibody 514 (Evans and
Morrey, 1987; Sitbon et al., 1985).
RNase protection assay
Total RNA from brain tissue was prepared using Trizol
reagent (Invitrogen, Carlsbad, CA) according to manufacturers'
instructions. For examination of mRNA from NSC, confluent
flasks of cells were lysed using Trizol reagent and processed for
RNA according to manufacturers' instructions. RNA was
quantified by spectroscopy at 260 nm diluted to equal
concentration in hybridization buffer (BD Biosciences) and
stored at −80 °C until use. The RNA was then analyzed for
specific cytokine mRNA using the RiboQuant System (BD
Biosciences) as previously described (Peterson et al., 2001). P32-
labeled protected probe was quantified for each gene of interest
using a STORM PhosphorImager (Amersham Biosciences,
Piscataway, NJ) and Image Quant software. Data were normal-
ized to L32 mRNA expression for each sample and then calcu-
lated as a ratio of gene expression relative to gene expression in
the positive control (RNA from Fr98-infected mice).
Preparation of RNA for real-time reverse transcriptase PCR
analysis
Total RNA from the cerebrum or cerebellum/brainstem
regions was isolated as described above for the RNAseProtection assay. The RNA was then treated with DNAse
(Ambion, Austin, TX) for 30 min to remove any contaminating
DNA, and purified over RNAeasy columns (Qiagen).
Primers and probes for gene detection
F4/80 mRNA expression was detected using the forward
primer F4/80-1958F (5′-TTA CGATGG AAT TCT CCT TGT
ATA TCA-3′), the reverse primer F4/80-2051R (5′-CAC AGC
AGG AAG GTG GCT ATG-3′), and probe F4/80-2001T
(6FAM-AGT CAT CTC CCT GGT ATG TCT TGC CTT GG-
TAMRA). Gfap mRNA expression was detected using the
forward primer GFAP-16F (5′-CGT TTC TCC TTG TCT CGA
ATG AC-3′), the reverse primer GFAP-112R (5′-TCG CCC
GTG TCT CCT TGA-3′), and probe GFAP-42T (6FAM-TCC
ACT CCC TGC CAG GGT GGA CTT-TAMRA). Primer and
probes from Rodent GAPDH Control Reagent kit (Applied
Biosystems) were used to detect Gapdh mRNA expression.
Real-time PCR analysis of gene expression
Reactions were run in triplicate using the one-step RT-
PCR master mix (Applied Biosystems) in a 10 μl volume
with approximately 10 ng of DNAse-treated total RNA,
500 nM of forward and reverse primers and 250 nM of
probe on an ABI PRISM 7900 Sequence Detection System
(Applied Biosystems, Foster City, CA). Lack of DNA
contamination was confirmed by running reactions without
reverse transcriptase. The cycle number at which each
sample reached a fixed fluorescence threshold (CT) was used
to quantify gene expression. Data were calculated as the
difference in CT value (log2) for Gapdh minus the CT value
of the gene of interest for each sample (ΔCT=CT Gapdh
−CT gene of interest) to control for variations in RNA
amounts in each sample. The data are presented as the fold
expression of the gene of interest relative to Gapdh. For
example, a value of one indicates the same level of mRNA
expression as Gapdh (ΔCT=0), whereas a value of two
indicates a two fold higher level of mRNA expression than
GAPDH (ΔCT=1).
Generation of probes for in situ hybridization
The generation of Ccl2(MCP-1) RNA in situ probes has
been previously described (Glabinski et al., 1996; Peterson et
al., 2004a, 2004b). Template DNA for the generation of Ccl2-
specific probes was kindly provided by Richard Ransohoff.
Digoxigenin (DIG)-labeled sense and anti-sense probes were
generated using the DIG RNA labeling kit (Roche Molecular
Biochemicals), T7 or T3 polymerase and 0.5 to 1 μg of
linearized template DNA following manufacturer's instruc-
tions. DIG-labeled probes were purified over RNAeasy
columns (Qiagen, Valencia, CA). Probe concentration was
calculated by limiting serial dilutions of the probes on nylon
membrane with comparison to a known standard (Roche
Molecular Biochemicals). Sense-strand probes were used as
negative controls.
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In situ hybridization was performed as previously described
(Peterson et al., 2004a, 2004b). In brief, brain tissues from Fr98,
Fr54-NSC, Fr54 or mock-NSC-inoculated mice were removed
at the time of clinical disease or the indicated times. Tissues
were embedded in paraffin and processed for in situ hybridiza-
tion analysis as described. DIG labeled sense and anti-sense
probes were diluted 1/100 in hybridization buffer with 20 μl of
probe used per section. DIG-labeled sense strands were used as
a negative control. The sections were incubated at 95 °C for
4 min. and hybridized overnight at 56 °C. Non-hybridized probe
was digested with 20 μg/ml of RNAse A (Roche) in 500 mM
NaCl, 10 mM Tris pH 8.0 with subsequent rinsing in 2XSSC
and incubating sections in 1× SSC, 50% formamide at 56 °C to
remove any remaining unbound probe. DIG-labeled probes
were detected with alkaline phosphatase (AP)-labeled anti-DIG
antibodies (Roche Molecular Biochemicals) using the Fast-Red
substrate (Roche Molecular Biochemicals). Sections were then
either counterstained with hematoxylin or used for immuno-
histochemistry. For subsequent immunohistochemistry analy-
sis, sections were blocked in 1% normal goat serum (NGS) in
PBS. Sections were then incubated with a 1/1000 dilution of
rabbit anti-glial fibrillary acidic protein (GFAP) (Dako,
Glostrup, Denmark) or a 1/100 dilution of rabbit anti-Iba1
(Wako, Richmond, VA), in 1% NGS. GFAP-positive cells were
detected using AP-conjugated anti-rabbit antibodies (Jackson
Immunoresearch, West Grove PA). Sections were developed
with DAB substrate (Sigma-Aldrich, St. Louis, MO), counter-
stained with hematoxylin and coverslipped.
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